DarioHealth Corp.
DRIO
$7.99
$0.496.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.36M | 24.73M | 27.15M | 28.03M | 27.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.36M | 24.73M | 27.15M | 28.03M | 27.04M |
| Cost of Revenue | 8.02M | 7.89M | 8.28M | 8.58M | 8.75M |
| Gross Profit | 14.34M | 16.84M | 18.87M | 19.46M | 18.30M |
| SG&A Expenses | 35.53M | 36.66M | 37.95M | 41.64M | 46.10M |
| Depreciation & Amortization | 1.67M | 2.78M | 3.94M | 4.74M | 5.03M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.01M | 63.76M | 68.73M | 76.60M | 84.06M |
| Operating Income | -36.66M | -39.03M | -41.58M | -48.57M | -57.02M |
| Income Before Tax | -41.61M | -42.14M | -44.02M | -44.64M | -44.60M |
| Income Tax Expenses | 105.00K | 177.00K | 164.00K | 164.00K | -1.85M |
| Earnings from Continuing Operations | -41.71 | -42.32 | -44.18 | -44.80 | -42.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.71M | -42.32M | -44.18M | -44.80M | -42.75M |
| EBIT | -36.66M | -39.03M | -41.58M | -48.57M | -57.02M |
| EBITDA | -33.52M | -34.29M | -35.26M | -41.21M | -49.59M |
| EPS Basic | -11.40 | -11.85 | -13.80 | -11.95 | -13.10 |
| Normalized Basic EPS | -8.49 | -9.17 | -10.90 | -11.90 | -12.80 |
| EPS Diluted | -11.40 | -11.85 | -13.80 | -11.95 | -13.10 |
| Normalized Diluted EPS | -8.49 | -9.17 | -10.90 | -11.90 | -12.80 |
| Average Basic Shares Outstanding | 15.90M | 11.93M | 10.81M | 10.32M | 9.68M |
| Average Diluted Shares Outstanding | 15.90M | 11.93M | 10.81M | 10.32M | 9.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |